Author

Carlos H. Arteaga

OpenAlex ID: A5063765259

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers

2022 · Renée E. Michels, Carlos H. Arteaga, et al. · Applied Health Economics and Health Policy · 11

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

2023 · Nurullah Akkoç, Carlos H. Arteaga, et al. · Rheumatology and Therapy · 4

Works count: 2

Citation count: 15

H-index: 2

I10-index: 1